An episode of major depression can be crippling, impairing the ability to sleep, work, or eat. But the drugs available to treat depression can take weeks or even months to start working. Researchers have discovered one reason the drugs take so long to work, and their finding could help scientists develop faster-acting drugs in the future.
UI CDR pushes the edge of what is possible.
We help teachers to better manage disruptive classrooms, make the wounds of PTSD visible, and search for signs of depression in the blood stream. We are committed to new strategies, new treatments, novel approaches to the most vexing mental health issues of our time.
UI CDR is making this happen. We reorganized departments, research centers, and clinical groups across campus to make this a reality. We are networked with likeminded centers throughout the country who share this same vision to realize tomorrow’s medicine today.
Thinking creatively about pioneering solutions has a long running history at UIC. Our Department of Psychiatry contributed to over a century of firsts: the first children’s guidance center, the first community-based approaches to psychology, the first electroencephalogram (EEG), and the first use of meta-analysis as a tool to pool scientific data.
Today, UI CDR is keeping this legacy alive through a commitment to pioneering research. From technology based interventions—smart phones, websites, text messaging, tablets—that provide an alternative to the traditional clinical model to training physicians, social workers, midwives, teachers, coaches, attendees, and others to provide frontline mental health opportunities. UI CDR pushes the edge of what is possible.
The Wall Street Journal published a story on BiAffect, the phone app designed to predict and monitor manic and depressive episodes. Dr. Alex Leow and Dr.
Dr. Scott Langenecker, Associate Director of the UI Center on Depression and Resilience, was featured on WTTW’s news program Chicago Tonight to talk about the rising toll and what can be done to reduce the numbers and help people in crisis.
Sending patients with depression to get a brain scan before going on antidepressants may help doctors determine whether or not antidepressants will be effective. UICDR Researcher Dr. Scott Langenecker's new study takes an important step toward individualized medicine for depression treatment.
Neurology Today on Pioneering UICDR Research by Dr. Scott Langenecker Takes a Different Look at Standard fMRI Data
In a standard fMRI experiment, increased regional brain activity is detected by change in blood flow. UICDR researcher Dr. Scott Langenecker processed the data differently, looking not for activity in individual regions, but instead identifying multiple regions whose activities were correlated.
In April 2016, the Robert Wood Johnson Foundation launched the Mood Challenge, an open call to tech entrepreneurs, innovators and mental health practitioners to leverage Apple’s ResearchKit to create new technologies t
UIC App Designed to Track Bipolar Disorder Wins Robert Wood Johnson Foundation-funded Mood Challenge for Research Kit
Doctor Alex Leow, associate professor of psychiatry in the UIC College of Medicine and associate professor of bioengineering and computer science, and Peter Nelson, professor of computer science and dean of the UIC College of Engineering, discussed their award-winning app, BiAffect, on Chicago To
An emotionally riveting memoir from local author Ally Golden,
Discover Magazine ranks its Top #100 science stories each year.
Depression is among the most common mental health conditions affecting young adults. In a 2015 survey of 43,210 undergraduate students across 72 U.S.
Dr. Rasenick’s work has focused on G protein signaling in the nervous system and the relationship of neurotransmitter activation to rapid modification of the cytoskeleton.
Joining the University in 2009, Dr. Leow received clinical training in Psychiatry and research training in biomedical imaging, both at UCLA. Having co-authored more than 70 articles, Dr. Leow's current research interests focus on developing novel probabilistic reconstruction, tractography, and network analyses techniques for high angular resolution diffusion imaging (HARDI) and their clinical applications.